Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Ribosome | R-HSA-5368277 | map03010 | SB-202190 | 2895 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | SB-202190 | 2895 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | SB-202190 | 2895 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | naftidrofuryl | 4417 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | naftidrofuryl | 4417 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | naftidrofuryl | 4417 | drug-path |
SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | naftidrofuryl | 4417 | drug-path |
Shigellosis | 0 | map05131 | naftidrofuryl | 4417 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | naftidrofuryl | 4417 | drug-path |
Non-homologous end-joining | R-HSA-5693571 | map03450 | naftidrofuryl | 4417 | drug-path |
Gap junction | R-HSA-190861 | map04540 | naftidrofuryl | 4417 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | pentoxyverine | 54562 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | pentoxyverine | 54562 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | pentoxyverine | 54562 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | pentoxyverine | 54562 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pentoxyverine | 54562 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | pentoxyverine | 54562 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | pentoxyverine | 54562 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | clomifene | 1548955 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | clomifene | 1548955 | drug-path |